Literature DB >> 16703590

MEP latency shift after implantation of deep brain stimulation systems in the subthalamic nucleus in patients with advanced Parkinson's disease.

Ute Hidding1, Tobias Bäumer, Hartwig Roman Siebner, Cüneyt Demiralay, Carsten Buhmann, Thomas Weyh, Christian Moll, Wolfgang Hamel, Alexander Münchau.   

Abstract

Deep brain stimulation (DBS) into the subthalamic nucleus (STN) is a highly effective treatment for advanced Parkinson's disease (PD). The consequences of STN stimulation on intracortical and corticospinal excitability have been addressed in a few studies using transcranial magnetic stimulation (TMS). Although excitability measurements were compared between the STN stimulation OFF and ON condition, in these experiments, there are no longitudinal studies examining the impact of electrode implantation per se on motor excitability. Here, we explored the effects of STN electrode implantation on resting motor thresholds (RMT), motor evoked potential (MEP) recruitment curves, and MEP onset latencies on 2 consecutive days before and shortly after STN surgery with the stimulator switched off, thus avoiding the effects of chronic DBS on the motor system, in 8 PD patients not taking any dopaminergic medication. After surgery, RMT and MEP recruitment curves were unchanged. In contrast, MEP onset latencies were significantly shorter when examined in relaxed muscles but were unchanged under preactivation. We hypothesize that postoperatively TMS pulses induced small currents in scalp leads underneath the TMS coil connecting the external stimulator with STN electrodes leading to inadvertent stimulation of fast-conducting descending neural elements in the vicinity of the STN, thereby producing submotor threshold descending volleys. These "conditioning" volleys probably preactivated spinal motor neurons leading to earlier suprathreshold activation by the multiple corticospinal volleys produced by TMS of the motor cortex. These TMS effects need to be considered when interpreting results of excitability measurements in PD patients after implantation of STN electrodes. (c) 2006 Movement Disorder Society.

Entities:  

Mesh:

Year:  2006        PMID: 16703590     DOI: 10.1002/mds.20951

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  9 in total

Review 1.  Low intensity transcranial electric stimulation: Safety, ethical, legal regulatory and application guidelines.

Authors:  A Antal; I Alekseichuk; M Bikson; J Brockmöller; A R Brunoni; R Chen; L G Cohen; G Dowthwaite; J Ellrich; A Flöel; F Fregni; M S George; R Hamilton; J Haueisen; C S Herrmann; F C Hummel; J P Lefaucheur; D Liebetanz; C K Loo; C D McCaig; C Miniussi; P C Miranda; V Moliadze; M A Nitsche; R Nowak; F Padberg; A Pascual-Leone; W Poppendieck; A Priori; S Rossi; P M Rossini; J Rothwell; M A Rueger; G Ruffini; K Schellhorn; H R Siebner; Y Ugawa; A Wexler; U Ziemann; M Hallett; W Paulus
Journal:  Clin Neurophysiol       Date:  2017-06-19       Impact factor: 3.708

Review 2.  Contribution of transcranial magnetic stimulation to assessment of brain connectivity and networks.

Authors:  Mark Hallett; Riccardo Di Iorio; Paolo Maria Rossini; Jung E Park; Robert Chen; Pablo Celnik; Antonio P Strafella; Hideyuki Matsumoto; Yoshikazu Ugawa
Journal:  Clin Neurophysiol       Date:  2017-09-05       Impact factor: 3.708

3.  Dissociation of motor symptoms during deep brain stimulation of the subthalamic nucleus in the region of the internal capsule.

Authors:  Weidong Xu; Svjetlana Miocinovic; Jianyu Zhang; Kenneth B Baker; Cameron C McIntyre; Jerrold L Vitek
Journal:  Exp Neurol       Date:  2010-08-14       Impact factor: 5.330

Review 4.  Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research.

Authors:  Simone Rossi; Mark Hallett; Paolo M Rossini; Alvaro Pascual-Leone
Journal:  Clin Neurophysiol       Date:  2009-10-14       Impact factor: 3.708

Review 5.  Safety of transcranial magnetic stimulation in Parkinson's disease: a review of the literature.

Authors:  Matthew Vonloh; Robert Chen; Benzi Kluger
Journal:  Parkinsonism Relat Disord       Date:  2013-03-07       Impact factor: 4.891

6.  Benefits of pallidal stimulation in dystonia are linked to cerebellar volume and cortical inhibition.

Authors:  Anna Fečíková; Robert Jech; Václav Čejka; Václav Čapek; Daniela Šťastná; Ivana Štětkářová; Karsten Mueller; Matthias L Schroeter; Filip Růžička; Dušan Urgošík
Journal:  Sci Rep       Date:  2018-11-21       Impact factor: 4.379

7.  Safety Study of Combination Treatment: Deep Brain Stimulation and Transcranial Magnetic Stimulation.

Authors:  Hamzah Magsood; Farheen Syeda; Kathryn Holloway; Ivan C Carmona; Ravi L Hadimani
Journal:  Front Hum Neurosci       Date:  2020-04-03       Impact factor: 3.169

8.  Suppression of beta oscillations in the subthalamic nucleus following cortical stimulation in humans.

Authors:  L M F Doyle Gaynor; A A Kühn; M Dileone; V Litvak; A Eusebio; A Pogosyan; A G Androulidakis; S Tisch; P Limousin; A Insola; P Mazzone; V Di Lazzaro; P Brown
Journal:  Eur J Neurosci       Date:  2008-07-24       Impact factor: 3.386

Review 9.  Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines.

Authors:  Simone Rossi; Andrea Antal; Sven Bestmann; Marom Bikson; Carmen Brewer; Jürgen Brockmöller; Linda L Carpenter; Massimo Cincotta; Robert Chen; Jeff D Daskalakis; Vincenzo Di Lazzaro; Michael D Fox; Mark S George; Donald Gilbert; Vasilios K Kimiskidis; Giacomo Koch; Risto J Ilmoniemi; Jean Pascal Lefaucheur; Letizia Leocani; Sarah H Lisanby; Carlo Miniussi; Frank Padberg; Alvaro Pascual-Leone; Walter Paulus; Angel V Peterchev; Angelo Quartarone; Alexander Rotenberg; John Rothwell; Paolo M Rossini; Emiliano Santarnecchi; Mouhsin M Shafi; Hartwig R Siebner; Yoshikatzu Ugawa; Eric M Wassermann; Abraham Zangen; Ulf Ziemann; Mark Hallett
Journal:  Clin Neurophysiol       Date:  2020-10-24       Impact factor: 4.861

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.